Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000445242 | SCV000535933 | uncertain significance | not provided | 2017-01-10 | criteria provided, single submitter | clinical testing | The V628L variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The V628L variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position where amino acids with similar properties to Valine are tolerated across species. However, a missense variant in a nearby residue (S627P) has been reported in the Human Gene Mutation Database in association with GSDII (Stenson et al., 2014). In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. |
Natera, |
RCV001835806 | SCV002092074 | uncertain significance | Glycogen storage disease, type II | 2021-01-29 | no assertion criteria provided | clinical testing |